Clinical analysis of concomitant valve replacement and bipolar radiofrequency ablation in 191 patients.
OBJECTIVE
The study objective was to evaluate the safety and efficacy of concomitant bipolar radiofrequency ablation and heart valve replacement in patients with rheumatic heart disease and atrial fibrillation.


METHODS
A total of 191 patients with rheumatic heart disease and chronic atrial fibrillation underwent valve replacement with concomitant bipolar radiofrequency ablation. There were 78 male and 113 female patients with a mean age of 46.0 ± 9.1 years and an atrial fibrillation duration of 43.7 ± 15.4 months. Valve replacement surgery included mitral valve replacement in 121 patients, mitral and aortic valve replacement in 59 patients, mitral and tricuspid valve replacement in 8 patients, and triple valve replacement in 3 patients. All patients received oral antiarrhythmic drugs for 3 to 6 months postoperatively. Follow-up electrocardiography and color Doppler echocardiography were performed postoperatively.


RESULTS
The mean aortic crossclamping time was 84.0 ± 25.5 minutes, and cardiopulmonary bypass time was 139.4 ± 39.1 minutes. There was no abnormal bleeding due to bipolar radiofrequency ablation. Three patients (1.57%) died of low cardiac output syndrome in hospital at 2, 3, and 5 days after surgery. Major perioperative complications include reoperation for bleeding (n = 1), reoperation for wound infection (n = 1), intra-aortic balloon pump placement (n = 2), and renal failure (n = 2). All other patients were discharged without complications. The mean follow-up time was 17.4 ± 11.8 months with a follow-up rate of 95.3%. There were no cases of late death, complete atrioventricular block, or anticoagulation-induced complications. Of 158 patients who were followed up for 1 year, sinus rhythm was maintained in 125 (79.11%).


CONCLUSIONS
Concomitant bipolar radiofrequency ablation is an effective and safe technique for treating atrial fibrillation in patients with rheumatic heart disease undergoing valve replacement, with promising follow-up results.
Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
Li
L
Dong
Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
Bo
B
Fu
Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xiao
X
Teng
Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
Hong-Sheng
HS
Yuan
Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
Shu-Lin
SL
Zhao
Department of Oncology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: renlihx@163.com.
Li
L
Ren
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000150:complications* / Q000601:surgery*; D017115:Catheter Ablation; D002908:Chronic Disease; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications* / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000150:complications* / Q000601:surgery*; D055815:Young Adult